<DOC>
	<DOCNO>NCT02468583</DOCNO>
	<brief_summary>This study double-blind , randomize , parallel group , proof concept study compare FX006 Kenalog®-40 ( triamcinolone acetonide injectable suspension , USP ) patient post-traumatic osteoarthritis knee .</brief_summary>
	<brief_title>Proof Concept Study Comparing FX006 Kenalog®-40 Patients With Post-Traumatic Osteoarthritis Knee</brief_title>
	<detailed_description>This study double-blind , randomize , parallel group , proof concept study patient post-traumatic osteoarthritis ( PTOA ) knee . Approximately 124 eligible patient randomize one two treatment group ( 1:1 ) treat single intra-articular ( IA ) injection : - 40 mg FX006 - 40 mg Kenalog®-40 ( triamcinolone acetonide injectable suspension , USP ) Each prospective patient undergo screen evaluation confirm diagnosis PTOA knee concurrence eligibility criterion . Patients treat Day 1 ( Baseline ) return clinic Weeks 4 , 8 12 evaluation safety efficacy .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Willingness ability comply study procedure visit schedule ability follow verbal write instruction Male female ≥20 ≤50 year age Diagnosis posttraumatic OA knee KellgrenLawrence ( KL ) Grade 2 3 index knee within 6 month prior Screening Qualifying mean score 24h average pain score ( 010 numeric rating scale ) Body mass index ( BMI ) ≤ 40 kg/m2 Willingness abstain use restrict medication therapy study Prior osteotomy index knee Any condition could possibly confound patient 's assessment index knee pain judgement Investigator ( i.e. , ipsilateral hip OA , gout , radicular low back pain hip pain refer knee could cause misclassifcation , pain area low extremeties back equal great index knee pain ) Fibromyalgia , Reiter 's syndrome , rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis , arthritis associate inflammatory bowel disease History , clinical sign symptom active infection index knee Crystal disease index knee within one month Screening Disease secondary surgical treatment Shatzker grade IV , V , VI tibial plateau fracture ( OTA classification C2 C3 ) ; surgical treatment OTA calssifcation C2 C3 distal femur fracture ; &gt; 2mm articular incongruity surgery IA corticosteroid ( investigational market ) joint within 3 month Screening IA hyaluronic acid ( investigational market ) index knee within 6 month Screening Intramuscular ( IM ) oral corticosteroid ( investigational market ) within 1 month Screening Any IA investigational drug/biologic within 6 month Screening Prior use FX006 Prior arthroplasty type index knee planned/anticipated surgery index knee study period Type 1 Type 2 diabetes require insulin Women childbearing potential use effective contraception pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Post-traumatic</keyword>
	<keyword>Knee</keyword>
	<keyword>Pain</keyword>
	<keyword>Steroid</keyword>
	<keyword>Intra-articular</keyword>
	<keyword>Injection</keyword>
</DOC>